Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 4;11(2):e4013.
doi: 10.7759/cureus.4013.

Clinical Experience with Hemopatch® as a Dural Sealant in Cranial Neurosurgery

Karl-Michael Schebesch  1 , Alexander Brawanski  1
Affiliations

Clinical Experience with Hemopatch® as a Dural Sealant in Cranial Neurosurgery

Karl-Michael Schebesch et al. Cureus. .

Abstract

Background: Herein, we report our clinical experience with the novel polyethylene glycol-covered matrix dural onlay, Hemopatch® (Baxter Deutschland GmbH, Unterschleißheim, Germany) for the prevention of postoperative cerebrospinal fluid (CSF) fistulas.

Methods: Retrospectively, 22 consecutive patients (11 females, 11 males, mean age: 49.8 years, range: 15-77 years) with oncological and vascular intracranial lesions were included in this study. In all patients, the Hemopatch was applied as the dural onlay. The accuracy of the primary dural sutures was distinguished into 1) no visible gaps, 2) small gaps < 3 mm, and 3) large gaps > 3 mm. We evaluated the patient charts, surgical reports, and postoperative images. The median follow-up was three months. We recorded any wound healing disorder, such as infection or CSF fistula, and postoperative hemorrhage resulting in surgical revision.

Results: Supratentorial, infratentorial, and transsphenoidal approaches were conducted in 17, four, and one patient, respectively. Accurate sutures without visible gaps, small gaps, and large gaps were covered with the Hemopatch in 11, eight, and three patients. One patient developed a CSF fistula (4.5%), one patient had a wound infection (4.5%), and in one patient, a remote cerebellar hemorrhage occurred (unrelated to the dural closure) (4.5%). Thus, the surgical revision rate due to wound healing disorders was 9% (2/22).

Conclusion: It is safe and feasible to use the Hemopatch as a dural sealant. The rate of postoperative wound healing disorders in our population was in the lower range of reported surgical revision rates after supra-/infratentorial craniotomies. However, prospective and controlled clinical trials are still warranted.

Keywords: dura substitute; dural sealant; hemopatch.

PubMed Disclaimer

Conflict of interest statement

The authors have declared financial relationships, which are detailed in the next section.

Figures

Figure 1
Figure 1. Accurate suturing of the dural rims (no visible gaps)
Figure 2
Figure 2. Small gaps after dural suturing (< 3 mm)
Figure 3
Figure 3. Large gaps after dural suturing (> 3 mm)
Figure 4
Figure 4. Additional covering with the Hemopatch
Figure 5
Figure 5. Covered with the Hemopatch
Figure 6
Figure 6. Covered with the Hemopatch
See this image and copyright information in PMC

References

    1. Risk factors for postoperative CSF leakage after elective craniotomy and the efficacy of fleece-bound tissue sealing against dural suturing alone: a randomized controlled trial. Hutter G, von Felten S, Sailer MH, Schulz M, Mariani L. J Neurosurg. 2014;121:735–744. - PubMed
    1. Evaluation of the use of BioGlue in neurosurgical procedures. Kumar A, Maartens NF, Kaye AH. J Clin Neurosci. 2003;10:661–664. - PubMed
    1. Prevention and management of cerebrospinal fluid leak following vestibular schwannoma surgery. Fishman AJ, Marrinan MS, Golfinos JG, Cohen NL, Roland JT Jr. Laryngoscope. 2004;114:501–505. - PubMed
    1. Management of 1000 vestibular schwannomas (acoustic neuromas): the facial nerve--preservation and restitution of function. Samii M, Matthies C. Neurosurgery. 1997;40:684–694. - PubMed
    1. Risk factors of neurosurgical site infection after craniotomy: a systematic review and meta-analysis. Fang C, Zhu T, Zhang P, Xia L, Sun C. Am J Infect Control. 2017;45:123–134. - PubMed

LinkOut - more resources